‘High‑T Military’ Plan Sparks Fierce Medical Backlash

Defense Secretary Pete Hegseth has announced that military personnel aged 30 and older will undergo mandatory screening for testosterone deficiency. The move, aimed at optimizing performance and health, has been met with caution from medical experts who warn about the risks of population-level screening and potential misdiagnoses.
‘High‑T Military’ Plan Sparks Fierce Medical Backlash

‘High‑T Military’ Plan Sparks Fierce Medical Backlash
US Defense Secretary Pete Hegseth’s push to create a more physically robust, “high‑T” force by screening older troops for low testosterone has collided with warnings from hormone specialists who call the strategy risky and misguided.

Timeline of the rollout and reaction

On July 15, reports surfaced that US troops would receive testosterone treatment as part of a new initiative “to make them strong,” tying the policy to a broader political focus on virility and low sperm counts on the American right.

Two days later, on July 17, Hegseth formally announced that all active duty and reserve personnel aged 30 and older will face mandatory screening for testosterone deficiency during annual health assessments, with under‑30 troops allowed to request tests. In a short video message, he framed the move as a way to “optimize your performance, your resilience, and your long-term health,” insisting it was not about “artificial enhancement” but about restoring capabilities and ensuring troops “have the biological foundation required to sustain the fight.”

Doctors’ alarm over ‘population‑level’ screening

Within days, endocrinologists and medical societies responded with sharp concern. The Endocrine Society issued a statement warning there is “insufficient evidence to support a general recommendation to perform population-level screening for hypogonadism in asymptomatic men with measurement of blood testosterone level.”

Professor Bradley Anawalt, chief of medicine at the University of Washington Medical Center, called the plan “a great big fat ‘Oh, no,’” arguing that “we’re turning the clock back on rational healthcare” and raising alarms about ethics, health consequences, and unnecessary or incorrect evaluations. Experts highlight that diagnosing low testosterone is clinically complex, tests can be unreliable, and testosterone replacement therapy itself carries significant risks.

Political symbolism vs. clinical caution

Supporters inside the Pentagon present the program as a readiness tool to strengthen warfighters’ bodies and longevity. Critics, however, see a politically charged experiment in population‑wide hormone manipulation that could expose thousands of healthy troops to unnecessary medicalization and side effects, with little evidence it will actually improve battlefield performance.

Continue reading https://foxvector.com/stories/019f7e55-5071-3c12-7253-18056254f92f

Write a comment